Human Circulating MicroRNA-1 and MicroRNA-126 as Potential Novel Indicators for Acute Myocardial Infarction
暂无分享,去创建一个
Yan Wang | Chen Chen | Wei Gong | Shenglan Yang | W. Gong | Q. Duan | Daowen Wang | Yan Wang | Shenglan Yang | Feng Wang | Fuqiong Chen | Guangwen Long | Dao Wen Wang | Guangwen Long | Feng Wang | Quanlu Duan | Fuqiong Chen | Cheng Chen
[1] M. Rossbach. Small non-coding RNAs as novel therapeutics. , 2010, Current molecular medicine.
[2] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[3] J. Bauersachs. Regulation of Myocardial Fibrosis by MicroRNAs , 2010, Journal of cardiovascular pharmacology.
[4] Fred S Apple,et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. , 2007, Circulation.
[5] H. Jäck,et al. Serum microRNAs as powerful cancer biomarkers. , 2010, Biochimica et biophysica acta.
[6] N. Iwai,et al. The Monocyte Chemotactic Protein-1 Gene May Contribute to Hypertension in Dahl Salt-Sensitive Rats , 2007, Hypertension Research.
[7] D. Glavač,et al. MicroRNA Microarray Expression Profiling in Human Myocardial Infarction , 2010, Disease markers.
[8] P. Qi,et al. Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection , 2011, PloS one.
[9] K. Fogarty,et al. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis , 2010, Nature.
[10] Robert H Christenson,et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. , 2007, Clinical chemistry.
[11] Dmitry Terentyev,et al. MicroRNA-1 and -133 Increase Arrhythmogenesis in Heart Failure by Dissociating Phosphatase Activity from RyR2 Complex , 2011, PloS one.
[12] E. van Rooij,et al. Therapeutic Advances in MicroRNA Targeting , 2011, Journal of cardiovascular pharmacology.
[13] Federica Limana,et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction , 2010, European heart journal.
[14] Ning Wang,et al. MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation , 2010, Circulation.
[15] Offer Amir,et al. Serum levels of microRNAs in patients with heart failure , 2012, European journal of heart failure.
[16] D. Glavač,et al. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 Are Dysregulated in Human Myocardial Infarction , 2009, Cardiology.
[17] Decheng Yang,et al. MicroRNA: an Emerging Therapeutic Target and Intervention Tool , 2008, International journal of molecular sciences.
[18] M. Ivan,et al. microRNA: emerging therapeutic targets in acute ischemic diseases. , 2010, Pharmacology & therapeutics.
[19] Wei Gao,et al. Altered expression of microRNAs in the myocardium of rats with acute myocardial infarction , 2010, BMC cardiovascular disorders.
[20] Chaoqian Xu,et al. Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA‐1 , 2009, British journal of pharmacology.
[21] Yanjie Lu,et al. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases , 2010, Acta Pharmacologica Sinica.
[22] Q. Cui,et al. An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.
[23] I. Rigoutsos,et al. Gene-expression forum: Decoy for microRNAs , 2010, Nature.
[24] Chaoqian Xu,et al. MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. , 2009, Cardiovascular research.
[25] Jayaram Radhakrishnan,et al. LRP6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors , 2007, Science.
[26] D. Moazed. Small RNAs in transcriptional gene silencing and genome defence , 2009, Nature.
[27] M. Abdellatif. MicroRNA: redefining mechanisms in cardiovascular diseases. , 2010, Journal of cardiovascular pharmacology.
[28] E. Olson,et al. MicroRNA-218 Regulates Vascular Patterning by Modulation of Slit-Robo Signaling , 2010, Circulation research.
[29] M. Medvedovic,et al. MicroRNA-494 Targeting Both Proapoptotic and Antiapoptotic Proteins Protects Against Ischemia/Reperfusion-Induced Cardiac Injury , 2010, Circulation.
[30] Xuemei Chen,et al. Degradation of microRNAs by a Family of Exoribonucleases in Arabidopsis , 2008, Science.
[31] Volker Adams,et al. Cardiovascular Effects of Exercise Training: Molecular Mechanisms , 2010, Circulation.
[32] G. Hirokawa,et al. Plasma miR-208 as a biomarker of myocardial injury. , 2009, Clinical chemistry.
[33] W. Rottbauer,et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.
[34] Wei Wu. MicroRNA: Potential Targets for the Development of Novel Drugs? , 2010, Drugs in R&D.
[35] Chaoqian Xu,et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 , 2011, Nature Medicine.
[36] Hui Zhou,et al. Insulin-Like Growth Factor-1 Receptor Is Regulated by microRNA-133 during Skeletal Myogenesis , 2011, PloS one.
[37] Anthony Boureux,et al. Maternal mRNA deadenylation and decay by the piRNA pathway in the early Drosophila embryo , 2010, Nature.
[38] M. Latronico,et al. Emerging role of microRNAs in cardiovascular biology. , 2007, Circulation research.
[39] I. Wistuba,et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs , 2010, Nature.
[40] Stefanie Dimmeler,et al. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[41] W. Yue,et al. MicroRNA-21 Overexpression Contributes to Vestibular Schwannoma Cell Proliferation and Survival , 2010, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[42] Kang Li,et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. , 2010, Biochemical and biophysical research communications.